₹521.8
1.56%
Low
Day's Volatility:5.18%
High
3.62%
56.21%
Low
52 Weeks Volatility:63.84%
High
7.63%
Returns % | |
1 Month Return | 6.13 % |
3 Month Return | 48.56 % |
1 Year Return | 105.1 % |
Market Stats | |
Previous Close | ₹537.05 |
Open | ₹538.50 |
Volume | 2.20L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹5,251.86Cr |
Organisation | Shilpa Medicare Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Shilpa Medicare Ltd
Shilpa Medicare Ltd's Unit-4 facility in Jadcherla, Telangana, received GMP certification from AGES, Austria. The company also announced the launch of PEMRYDI RTU by its marketing partner Amneal Pharmaceuticals. Shilpa Medicare's share price touched a 52-week high of ₹558 after these announcements.
Shilpa Medicare Receives EU GMP Certificate for Telangana Facility - 17 Apr, 2024
Shilpa Medicare's Unit 4 facility in Jadcherla, Telangana has received the EU good manufacturing practice (GMP) certificate, allowing it to continue supplying medicines to various countries in the European Union. The company reported a consolidated net profit of Rs 4.58 crore in Q3 FY24 and its stock rallied by 6.14%.
Shilpa Medicare Receives GMP Certification for Unit 4 Facility - 16 Apr, 2024
Shilpa Medicare's unit 4 facility in Telangana has received the Good Manufacturing Practice certification from AGES, Austria. The certification will enable continued supply of medicines to various countries in the European Union.
Shilpa Medicare Raises Rs 500 Crore Through QIP Issue - 15 Apr, 2024
Shilpa Medicare has raised Rs 500 crore through a qualified institutional placement (QIP) issue, with participation from funds managed by Sunil Singhania and Madhusudan Kela. ICICI Prudential and Bandhan Mutual Fund also participated in the QIP issue, which was priced at Rs 455 per share.
Shilpa Medicare Raises Rs 500 Crore Through QIP - 13 Apr, 2024
Shilpa Medicare has successfully raised Rs 500 crore through a Qualified Institutional Placement (QIP) by allotting 1.09 crore equity shares to eligible institutional buyers at an issue price of Rs 455 per share.
Shilpa Medicare Shares Surge 27% in a Month - 12 Apr, 2024
Shilpa Medicare shares have gained 27% in the last month and 101% in the last year. However, its P/S ratio of 4x is higher than almost half the companies in India's Pharmaceuticals industry, and revenue growth has been inconsistent recently. Elevated P/S may not be rational, and there is considerable risk of share price declining if recent medium-term revenue trends continue.
Shilpa Medicare Launches QIP at Floor Price of Rs 477.33 Per Share - 09 Apr, 2024
Pharmaceutical company Shilpa Medicare has launched a Qualified Institutional Placement (QIP) to raise funds at a floor price of Rs 477.33 per share. The board authorized the QIP to raise up to Rs 500 crore and may offer a discount of up to 5%. The stock surged by 4.3%, reaching a 52-week high. Analysts predict positive momentum for the stock.
Shilpa Medicare Board Approves QIP - 08 Apr, 2024
Shilpa Medicare Ltd.'s board has approved a qualified institutional placement (QIP) at a floor price of Rs 477.33 per equity share. The Relevant Date for the purpose of the Issue is April 8, 2024.
Fundamentals of Shilpa Medicare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, SHILPAMED has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
MF Holding Up
Mutual Funds have increased holdings from 0.04% to 0.06% in Dec 2023 quarter
Price Rise
In the last 3 months, SHILPAMED stock has moved up by 48.6%
Retail Holding Up
Retail Investor have increased holdings from 40.99% to 41.41% in Dec 2023 quarter
Profit Spike
Netprofit is up for the last 4 quarters, -8.04 Cr → 4.58 Cr (in ₹), with an average increase of 291.0% per quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 122.4% return, outperforming this stock by 99.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.01% of holdings in Dec 2023 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 314.79 Cr → 288.7 Cr (in ₹), with an average decrease of 8.3% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 8.60% to 8.52% in Dec 2023 quarter
Shilpa Medicare Ltd in the last 5 years
Lowest (-7919.29x)
May 2, 2024
Today (-7672.14x)
May 3, 2024
Industry (62.63x)
May 3, 2024
Highest (503.73x)
February 21, 2023
Investors | Holdings % | Prev. 4 periods | 3M change |
---|---|---|---|
Promoter Holdings | 50.01% | 0.00 | |
Foreign Institutions | 8.52% | ||
Mutual Funds | 0.06% | 37.05 | |
Retail Investors | 41.41% | 1.04 | |
Others | 0% |
Technicals of Shilpa Medicare Ltd share
News & Events of Shilpa Medicare Ltd
Shilpa Medicare Ltd (SHILPAMED) share price today is ₹521.8
Shilpa Medicare Ltd is listed on NSE
Shilpa Medicare Ltd is listed on BSE
PE Ratio of Shilpa Medicare Ltd is -7672.14
PE ratio = Shilpa Medicare Ltd Market price per share / Shilpa Medicare Ltd Earnings per share
Today’s traded volume of Shilpa Medicare Ltd(SHILPAMED) is 2.20L.
Today’s market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹5251.86Cr.
Shilpa Medicare Ltd(SHILPAMED | Price |
---|---|
52 Week High | ₹561.6 |
52 Week Low | ₹228.5 |
Shilpa Medicare Ltd(SHILPAMED) share price is ₹521.8. It is down -7.09% from its 52 Week High price of ₹561.6
Shilpa Medicare Ltd(SHILPAMED) share price is ₹521.8. It is up 128.36% from its 52 Week Low price of ₹228.5
Shilpa Medicare Ltd(SHILPAMED | Returns |
---|---|
1 Day Returns | -15.25% |
1 Month Returns | 6.13% |
3 Month Returns | 48.56% |
1 Year Returns | 105.1% |